The NxStage System One.
Given the results of recent randomized controlled trials as well as staffing and budget challenges that today face many institutions across North America, a novel therapeutic approach is likely necessary to enable improvements in clinical outcomes for renal failure patients. The NxStage System One was developed to address these challenges. The system is an innovative, flexible device that delivers hemodialysis, hemofiltration, and/or ultrafiltration therapies to patients with renal failure or fluid overload. The unique characteristics of this system include a highly automated system design with a drop-in cartridge to facilitate training and simple operation; portable size and independence from dedicated infrastructure to minimize practical barriers to where therapy may be administered; use of high-quality premixed treatment fluids to enable capture of the potential clinical benefits of fluid purity without the hassles of local water treatment; and wide operating ranges to allow clinician flexibility in patient therapy prescriptions. In both the chronic and acute care environments, the System One presents clinicians with a new platform for delivering patient therapy improvements within real-world constraints.
Clark
William R
WR
NxStage Medical Inc., 439 South Union Street, Lawrence, MA 01843, USA.
Turk
Joseph E
JE
D004867:Equipment Design; D004869:Equipment Safety; D006801:Humans; D017060:Patient Satisfaction; D006435:Renal Dialysis / Q000295:instrumentation*; D014584:User-Computer Interface